Actavis plc, of Dublin, said the U.S. Court of Appeals for the Federal Circuit has reversed a lower court ruling that Actavis’ generic version of Shire plc’s (also of Dublin) Lialda (mesalamine extended-release tablets) infringes U.S. Patent No. 6,773,720 (the ‘720 Patent).